Adult Pulmonary Vascular Disease

Endovascular transatrial stenting of pulmonary vein stenosis after lung transplantation

Michaela Orlitova, Marc Gewillig, Jan Van Slambrouck, Dirk Vlasselaers, Bart Jacobs, Arne P. Neyrinck, Lieven Depypere, Laurent Godinas, Robin Vos, Geert M. Verleden, Dirk E. Van Raemdonck, Laurens J. CeulemansUniversity Hospitals Leuven. Belgium American Journal of TransplantationAm J Transplant 2023; 23: 111-114DOI: 10.1111/ajt.17202 AbstractPulmonary vein stenosis (PVS) and pulmonary vein occlusion (PVO) represent rare complications after […]

Endovascular transatrial stenting of pulmonary vein stenosis after lung transplantation Read More »

Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension

Catherine E. Simpson, Anjira S. Ambade, Robert Harlan, Aurelie Roux, Susan Aja, David Graham, Ami A. Shah, Laura K. Hummers, Anna R. Humnes, Jane A. Leopold, Evelyn M. Horn, Erika S. Berman-Rosenzweig, Gabrielle Grunig, Michaela A. Aldred, John Barnard, Suzy A. A. Comhair, W. H. Wilson Tang, Megan Griffiths, Franz Rischard, Robert P. Frantz, Serpil

Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension Read More »

Chemotherapy-induced pulmonary hypertension: role of alkylating agents

Benoît Ranchoux, Sven Günther, Rozenn Quarck, Marie-Camille Chaumais, Peter Dorfmüller, FabriceAntigny, Sébastien J. Dumas, Nicolas Raymond, Edmund Lau, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Gérald Simonneau, Kurt Stenmark, Sylvia Cohen-Kaminsky, Marc Humbert, David Montani, Frédéric PerrosUniversité Paris-Sud and Hôpital de Bicêtre. Centre Chirurgical Marie Lannelongue. Assistance Publique des Hôpitaux de Paris. KU Leuven. University of

Chemotherapy-induced pulmonary hypertension: role of alkylating agents Read More »

End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment

Anna R. Hemnes, Meredith E. Pugh, Alexander L. Newman, Ivan M. Robbins, James Tolle, Eric D. Austin, John H. NewmanVanderbilt University Medical Center. United States ChestChest 2011; 140: 1267-1273DOI: 10.1378/chest.11-0155 AbstractBackground: CO(2) excretion is impaired in pulmonary arterial hypertension (PAH) due to underlying vascular obstruction and increased dead space. Our aim was to determine whether resting end

End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment Read More »

Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis

Thomas P. Doyle, James E. Loyd, Ivan M. RobbinsVanderbilt University School of Medicine.United States American Journal of Respiratory and Critical Care MedicineAm J Repir Crit Care Med 2001; 164: 657-660DOI: 10.1164/ajrccm.164.4.2012132 AbstractMediastinal fibrosis is a rare consequence of infection with the fungus Histoplasma capsulatum that can lead to occlusion of large pulmonary arteries and veins and

Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis Read More »

Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis

Amanda L. Cook, Lourdes R. Prieto, Jeffrey W. Delaney, John F. RhodesDuke University Medical Center.United States American Journal of CardiologyAm J Cardiol 2006; 98: 407-410DOI: 10.1016/j.amjcard.2006.02.049 AbstractAfter radiofrequency ablation for atrial fibrillation, patients may develop pulmonary vein stenoses requiring stent angioplasty. The treatment options for when such patients develop in-stent stenoses are poorly defined. The investigators

Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis Read More »

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension

Franz P. Rischard, Roberto J. Bernardo, Rebecca R. Vanderpool, Deborah H. Kwon, Tuschar Acharya, Margaret M. Park, Austin Katrynuik, Michael Insel, Saad Kubba, Roberto Badagliacca, A. Brett Larive, Robert Naeije, Joe G. N. Garcia, Gerald J. Beck, Serpil C. Erzurum, Robert P. Frantz, Paul M. Hassoun, Anna R. Hemnes, Nicholas S. Hill, Evelyn M. Horn,

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension Read More »

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension

Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John WortHospital del Mar. Stellenbosch University and Tygerberg Hospital. University of Crete School of Medicine. The University of Chicago. Johns Hopkins University. Bayer AG. University of California Los Angeles

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension Read More »

NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

Susanne J. Maurer, Veronika Habdank, Jürgen Hörer, Peter Ewert, Oktay TutarelGerman Heart Centre Munich and Technical University of Munich. Ludwig-Maximilians Universität.Germany Journal of Clinical MedicineJ Clin Med 2023; 12DOI: 10.3390/jcm12093101 AbstractBackground: About 5-10% of adults with congenital heart disease (ACHD) will develop pulmonary arterial hypertension (PAH), which is associated with significant mortality. Studies on risk factors for

NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Read More »

Fatal Association of Eisenmenger Syndrome and Severe Preeclampsia

Said Benlamkaddem, Fatima Bouyermane, Djoudline Doughmi, Mohamed Adnane Berdai, Mustapha HarandouHassan II University Hospital. Sidi Mohamed Ben Abdellah University. Morocco CureusCureus 2023; 15DOI: 10.7759/cureus.37836 AbstractEisenmenger syndrome (ES) is the end stage of pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD), which can occur in patients with large, unrepaired cardiac shunts (ventricular septal defects (VSD),

Fatal Association of Eisenmenger Syndrome and Severe Preeclampsia Read More »

Scroll to Top